Oral IBAT Inhibitor Improves Cholestatic Itch in Primary Biliary Cholangitis

Watchdoq May 8, 2025
(MedPage Today) -- Linerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients with primary biliary cholangitis (PBC), the randomized phase III GLISTEN trial showed.
Among 238 patients...

Read Full Article